SCHEMBL245136

SCHEMBL245136

Cc1cccnc1SS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL245135 0.81 NOS3 (0.50)
SCHEMBL5640712 0.79
Ammonia Solution, Strong SCHEMBL1845719 0.77 NOS3 (0.46)
SCHEMBL14218666 0.77
SCHEMBL7615368 0.77
SCHEMBL27013272 0.77
SCHEMBL2113502 0.74 PKM (0.35)
SCHEMBL28171100 0.74
SCHEMBL12048608 0.74 KDM4E (0.45)
SCHEMBL1583838 0.74 NOS3 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070027310-A1 Novel ligands and methods for preparing same NATIONAL UNIVERSITY OF SINGAPORE (SG) 2007-02-01 US claimed
US-20040132981-A1 Novel ligands and methods for preparing same NATIONAL UNIVERSITY OF SINGAPORE (SG) 2004-07-08 US claimed
CN-1418111-A Novel Ligands and method for preparing same NAT UNIV SINGAPORE (SG) 2003-05-14 CN claimed
EP-1289561-A2 LIGAND CONJUGATES AND METHODS FOR PREPARING SAME NATIONAL UNIVERSITY OF SINGAPORE (SG) 2003-03-12 EP claimed
US-20010051348-A1 Novel ligands and methods for preparing same NATIONAL UNIVERSITY OF SINGAPORE (SG) 2001-12-13 US claimed
WO-2001054731-A2 LIGAND CONJUGATES AND METHODS FOR PREPARING SAME NATIONAL UNIVERSITY OF SINGAPORE (SG) 2001-08-02 WO claimed
CN-119455004-A Compositions, methods and uses comprising antibody-TLR agonist conjugates AMBRX公司 2025-02-18 CN disclosed
CN-119455003-A Compositions, methods and uses comprising antibody-TLR agonist conjugates AMBRX公司 2025-02-18 CN disclosed
CN-113660957-B Compositions, methods and uses comprising antibody-TLR agonist conjugates AMBRX公司 2024-12-13 CN disclosed
CN-118786140-A Anti-SARS-CoV-2 spike (S) antibodies and their use in treatment COVID-19 诺瓦瓦克斯股份有限公司 2024-10-15 CN disclosed
CN-117440833-A anti-HER 2 antibody-drug conjugates and uses thereof AMBRX公司 2024-01-23 CN disclosed
CN-109313200-B Bioanalytical methods for characterizing site-specific antibody-drug conjugates 豪夫迈·罗氏有限公司 2022-10-04 CN disclosed
CN-109071657-B Pharmaceutical compositions comprising bispecific antibody constructs 安进研发(慕尼黑)股份有限公司 2022-05-31 CN disclosed
CN-1137826-A Method and compositions for treatment of BCR-ABL associated leukemias and other cell proliferative disorders NEW YORK UNIV MEDICAL CENTER (US) 1996-12-11 CN disclosed
US-5468480-A Active against N-A-benzoyl-DL-arginine p-nitroanilide THE BOOTS COMPANY PLC (GB) 1995-11-21 US disclosed
US-5380656-A Chymopapain and method of purifying it on an inhibitory dipeptide affinity column THE BOOTS COMPANY PLC (GB) 1995-01-10 US disclosed
EP-0470136-B1 THERAPEUTIC AGENT BOOTS CO PLC (GB) 1994-06-22 EP disclosed
EP-0470136-A1 THERAPEUTIC AGENT. BOOTS CO PLC (GB) 1992-02-12 EP disclosed
CN-1047340-A Therapeutical agent BOOTS CO PLC (GB) 1990-11-28 CN disclosed
WO-1990013561-A1 THERAPEUTIC AGENT THE BOOTS COMPANY PLC (GB) 1990-11-15 WO disclosed